2. UroToday Home
  3. Video Lectures

The Prostate Cancer Foundation

Targeting the Regulator PTGES3 to Suppress Androgen Receptor in Resistant Prostate Cancer - Haolong Li
Annual PSMA & Beyond Meeting Focuses on Clinical Trials, Biomarkers, and Unmet Needs - Thomas Hope & Jeremie Calais
Investigational All-in-One CAR T-Cell Platform for Prostate Cancer - Nour Shobaki
Preclinical Study Evaluates p300 Protein in AR-Driven Prostate Cancer - Jie Luo
The Role of the Gut Microbiome in Prostate Cancer - Karen Sfanos
Addressing Urology Disparities Through Community Partnerships and Institutional Collaboration - Samuel Washington
Targeting NSD2 to Reverse Treatment Resistance in Advanced Prostate Cancer - Jia Li
Prostate Cancer Disparities: A Global Lens - Edward Christopher Dee
AR EcDNA Discovery in Advanced Prostate Cancer Study - George Zhao
VA Study Examines Use of Combination Therapies for mHSPC and Outcomes in Patients - Martin Schoen & Bruce Montgomery
Exercise Benefits In Prostate Cancer Active Surveillance - Dong-Woo Kang
Humanized Mice Reveal Role of Immune System in Prostate Cancer Therapy Efficacy - Steven Kregel
Antibody Drug Conjugate FOR46: Targeting CD46 in mCRPC in Phase 1b Trial - Nonna Shakhnazaryan
Extracellular Vesicles in Prostate Cancer: Multi-Omic Liquid Biopsy - Irene Casanova-Salas & Joaquin Mateo
NSD2's Role in Prostate Cancer: Uncovering AR's Functional Duality - Abhijit Parolia
Mentorship and Opportunity: Keys to Success in Medicine - Veda Giri
Genomic Alterations and Lutetium PSMA Response in Prostate Cancer - Alexandra Sokolova
Breaking Barriers in Cancer Treatment and Women's Leadership in Oncology - Ulka Vaishampayan
PSCA CAR T-Cell Therapy for Metastatic CRPC: Phase 1 Trial Results - Tanya Dorff
Mental Health and Prostate Cancer in the Veterans Population - Zachary Klaassen
BRCA2 and Beyond: Unraveling Genetic Drivers of Prostate Cancer Aggressiveness - Hiba Khan
Targeting EZH2 in Prostate Cancer: The Role of Mevrometostat in Preventing Neuroendocrine Differentiation - Michael Schweizer
ctDNA Fraction Predicts Response to Lutetium PSMA in TheraP Trial for mCRPC - Edmond Kwan
ZNF397 Deficiency: A Key Driver of Lineage Plasticity in Prostate Cancer Therapy Resistance - Ping Mu
Prostate Cancer Knowledge and Screening Barriers in Northern Tanzania: A Community-Based Study - Blandina Mmbaga & Nicholas Ngowi
Prostate Cancer Foundation's Guidelines for Black Men in the US - Isla Garraway
Comprehensive Multi-Region Sampling Reveals Extensive Genomic Heterogeneity in Metastatic Prostate Cancer - Alexander Wyatt
Targeting Myeloid Chemotaxis to Reverse Prostate Cancer Therapy Resistance - Johann De Bono
Novel Research Illuminates How CXCR7 Protein Interactions Promote Growth of Neuroendocrine Prostate Cancer - Jindan Yu
Nuclear Medicine Physician Discusses Career Path and Field Growth - Louise Emmett
The PCF Women in Science Forum: Empowering Female Researchers Through Networking and Mentorship - Veda Giri, Ayesha Shafi, & Claire Fletcher
The Complex Web of SPOP Mutations and STING1 Signaling in Prostate Cancer - Patrick Pilié
The Hidden Mechanisms Behind Rapid Tumor Evolution: AR Amplification on Extrachromosomal DNA I Prostate Cancer - Scott Dehm
Strategically Targeting Lactate in Prostate Cancer: Clinical Insights into Tumor Control and the Development of Next-Generation Therapeutics - Akash Patnaik
The Evolution of PSMA Theranostics: A 30-Year Journey with the Prostate Cancer Foundation - Andrea Miyahira
PSMA PET and Radioligand Therapy: A Comprehensive Two-Day Conference by UCLA and UCSF - Jeremie Calais & Thomas Hope
UCSD and the Prostate Cancer Foundation Unveil Second Annual Patient Summit: What to Expect - Rana McKay
AI-Based PTEN Loss Assessment: A Multicenter Retrospective Study on Prostate Cancer Metastasis - Tamara Jamaspishvili
Intrapatient Heterogeneity in Prostate Cancer: A Deep Dive into Androgen Receptor Alterations - Gerhardt Attard
Decoding the Complex Interplay of Hormone Therapy and Lineage Plasticity in Prostate Cancer - Amina Zoubeidi
RESPOND Study: A Multi-Faceted Exploration into Prostate Cancer's Racial Disparities - Scarlett Lin Gomez
The Impact of 'Sneaky Testosterone' on Post-Prostatectomy Treatment - Nima Sharifi
Translational Regulation in Prostate Cancer: The Akt/mTOR and MNK/eIF4E Pathways Unveiled - Daniela Brina
Club-Like Cells in Proliferative Inflammatory Atrophy of the Prostate - Karen Sfanos
The Role of Healthy Lifestyles in Prostate Cancer - June Chan & Rebecca Graff
Comprehensive Genomic Profiling and Treatment Patterns Across Ancestries in Advanced Prostate Cancer - Brandon Mahal
Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images - Tamara Lotan
Loss of SYNCRIP Unleashes APOBEC-Driven Mutagenesis, Tumor Heterogeneity and AR-Targeted Therapy Resistance in Prostate Cancer - Ping Mu
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry - Burcu Darst
A Mechanism of Tumor Suppression: Unveiling Transcription-Translation Conflict - Andrew Hsieh
Targeting Advanced Prostate Cancer with STEAP1 Chimeric Antigen Receptor T Cell and Tumor-Localized IL-12 Immunotherapy - John Lee
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer - David Quigley
Prostate Cancer and Veterans Health: A Spotlight on the Initiatives at the VA System - Hiten Patel
Patient-Driven Webtool Challenges Traditional Counseling in Prostate Cancer Germline Testing - Veda Giri
The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mCRPC - Susan Halabi
The Empowering Story of Women in Biostatistics: A Look into Dr. Susan Halabi's Career and the Mentors Who Shaped Her Path - Susan Halabi
Personal Passion Fuels Progress: Unraveling Prostate Cancer Aggressiveness in Black Men - Leanne Woods-Burnham
Exploring Unique Aspects of Prostate Cancer Research in the VA Healthcare System: Diversity, Disparities, and Future Directions - Isla P. Garraway
PSMA-Targeted Radioligand Therapy and Liquid Biopsy Characterizing PSMA Expression in Men with Metastatic Castration-Resistant Prostate Cancer - Andrew Armstrong
Overcoming Doubts and Striving for Excellence: Guiding Words for Women in Prostate Cancer Research - Elisabeth Heath
DLL3 Targeting Bispecifics: A New Hope for Tough-to-Treat Prostate Cancer Patients - Rahul Aggarwal
The Coffey – Holden Prostate Cancer Academy Meeting - Howard Soule and Charles Ryan
Report from the 2022 Coffey-Holden Prostate Cancer Academy Meeting - Kenneth Pienta, Andrea Miyahira, & Howard Soule
From Active Surveillance to Novel Biomarkers: A Seamless Approach to Prostate Cancer Research - Jeff Tosoian
Prostate Cancer Foundation Establishes Expert Health Equities Panel Creating Prostate Cancer Screening Guidelines for Black Men in the US - Michael Milken, Isla Garraway, & Kneeland Youngblood
From Blood to Diagnosis: the Role of ctDNA in Prostate Cancer Treatment - Alexander Wyatt
Targeting Tumor Marker B7-H3 with Engineered Natural Killer Cells - Nicholas Zorko
The Role of Tumor Immune Response in Castration-Resistant Prostate Cancer - Andrea Alimonti
Genomic Comparison Between African American Men & European American Men with Prostate Cancer - Isra Elhussin
Veterans Affair Care Program, Prostate Cancer Biorepository - Isla P. Garraway
The Prostate Cancer Foundation VA Health Initiatives, Executing Precision Oncology within the VA - Matthew Rettig & Isla Garraway
Addressing Prostate Cancer Health Disparities - Leanne Woods-Burnham
Contact-02: A Phase III Trial Shaping the Future of Metastatic Prostate Cancer Care - Neeraj Agarwal
Exploring the PROSPER Study: A Neoadjuvant Approach to Kidney Cancer - Mohamad Allaf
The AFT-19 Study: A Comprehensive Look at High-Risk Prostate Cancer Treatment - Rahul Aggarwal
Navigating the Challenges of Somatic Mutation Testing in Prostate Cancer - Joaquin Mateo
A Journey Through Prostate Cancer Research: Perspective on the Prostate Cancer Foundation's Impact - Philip Kantoff
Targeting Mechanisms of Lethal Prostate Cancer, the 2022 PCF TACTICAL Team Science Award - Charles Ryan and Howard Soule
The Prostate Cancer Foundation Team Science TACTICAL Awards - Howard Soule
Mentoring Women in Science - David Quinn
Ongoing Clinical Trials Evaluating The Efficacy of Targeted Radioligand Therapy - Shahneen Sandhu
Women in Science and The Prostate Cancer Foundation - Andrea Miyahira
The Use of Imaging for Patient Selection for PSMA Directed Therapies – Jeremie Calais